1. Product Overview
1.1.
Market
Definition
1.2.
Scope
of the Market
1.2.1.
Markets
Covered
1.2.2.
Years
Considered for Study
1.2.3.
Key
Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1.
Overview
of the Market
3.2.
Overview
of Key Market Segmentations
3.3.
Overview
of Key Market Players
3.4.
Overview
of Key Regions/Countries
3.5.
Overview
of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global
Beyond The Pill Market Outlook
5.1. Market Size & Forecast
5.1.1.
By
Value
5.2. Market Share & Forecast
5.2.1.
By Therapeutic
Area (Diabetes, Oncology, Cardiovascular Diseases, Asthma, Others)
5.2.2.
By
Offerings (Services, Monitoring, Assistance, Information, Education),
5.2.3.
By
Region
5.2.4.
By
Company (2023)
5.3. Market Map
6.
North
America Beyond The Pill Market Outlook
6.1. Market Size & Forecast
6.1.1.
By
Value
6.2. Market Share & Forecast
6.2.1. By Therapeutic
Area
6.2.2. By Offerings
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1.
United
States Beyond The Pill Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Therapeutic Area
6.3.1.2.2.
By
Offerings
6.3.2.
Canada
Beyond The Pill Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Therapeutic Area
6.3.2.2.2.
By
Offerings
6.3.3.
Mexico
Beyond The Pill Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Therapeutic Area
6.3.3.2.2.
By
Offerings
7.
Europe
Beyond The Pill Market Outlook
7.1. Market Size & Forecast
7.1.1.
By
Value
7.2. Market Share & Forecast
7.2.1.
By
Therapeutic Area
7.2.2.
By
Offerings
7.2.3.
By
Country
7.3. Europe: Country Analysis
7.3.1.
Germany
Beyond The Pill Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Therapeutic Area
7.3.1.2.2.
By
Offerings
7.3.2.
United
Kingdom Beyond The Pill Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Therapeutic Area
7.3.2.2.2.
By
Offerings
7.3.3.
Italy
Beyond The Pill Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By
Therapeutic Area
7.3.3.2.2.
By
Offerings
7.3.4.
France
Beyond The Pill Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Therapeutic Area
7.3.4.2.2.
By
Offerings
7.3.5.
Spain
Beyond The Pill Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Therapeutic Area
7.3.5.2.2.
By
Offerings
8.
Asia-Pacific
Beyond The Pill Market Outlook
8.1. Market Size & Forecast
8.1.1.
By
Value
8.2. Market Share & Forecast
8.2.1.
By
Therapeutic Area
8.2.2.
By
Offerings
8.2.3.
By
Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China
Beyond The Pill Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Therapeutic Area
8.3.1.2.2.
By
Offerings
8.3.2.
India
Beyond The Pill Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Therapeutic Area
8.3.2.2.2.
By
Offerings
8.3.3.
Japan
Beyond The Pill Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Therapeutic Area
8.3.3.2.2.
By
Offerings
8.3.4.
South
Korea Beyond The Pill Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Therapeutic Area
8.3.4.2.2.
By
Offerings
8.3.5.
Australia
Beyond The Pill Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Therapeutic Area
8.3.5.2.2.
By
Offerings
9.
South
America Beyond The Pill Market Outlook
9.1. Market Size & Forecast
9.1.1.
By
Value
9.2. Market Share & Forecast
9.2.1.
By
Therapeutic Area
9.2.2.
By
Offerings
9.2.3.
By
Country
9.3. South America: Country Analysis
9.3.1.
Brazil
Beyond The Pill Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Therapeutic Area
9.3.1.2.2.
By
Offerings
9.3.2.
Argentina
Beyond The Pill Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Therapeutic Area
9.3.2.2.2.
By
Offerings
9.3.3.
Colombia
Beyond The Pill Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Therapeutic Area
9.3.3.2.2.
By
Offerings
10. Middle East and Africa Beyond The Pill
Market Outlook
10.1.
Market
Size & Forecast
10.1.1. By Value
10.2.
Market
Share & Forecast
10.2.1. By Therapeutic Area
10.2.2. By Offerings
10.2.3. By Country
10.3.
MEA:
Country Analysis
10.3.1. South Africa Beyond The Pill
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By
Therapeutic Area
10.3.1.2.2.
By
Offerings
10.3.2. Saudi Arabia Beyond The Pill
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By
Therapeutic Area
10.3.2.2.2.
By
Offerings
10.3.3. UAE Beyond The Pill Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By
Therapeutic Area
10.3.3.2.2.
By
Offerings
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Merger
& Acquisition (If Any)
12.2.
Product
Launches (If Any)
12.3.
Recent
Developments
13. Porter’s Five Forces Analysis
13.1.
Competition
in the Industry
13.2.
Potential
of New Entrants
13.3.
Power
of Suppliers
13.4.
Power
of Customers
13.5.
Threat
of Substitute Products
14. Competitive Landscape
14.1.
F. Hoffmann-La Roche Ltd. (Flatiron Health, Inc.)
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT
Analysis
14.2.
Otsuka Pharmaceutical Co., Ltd.
14.3.
Amgen, Inc.
14.4.
AstraZeneca PLC
14.5.
Novartis AG
14.6.
Sanofi S.A.
14.7.
Novo Nordisk A/S
14.8.
Eli Lilly and Company
14.9.
Johnson & Johnson Services Inc.
14.10. Teva Pharmaceutical Industries Ltd.
15. Strategic Recommendations
16. About Us & Disclaimer